Gender |
|
|
|
Male |
74(77.9%) |
41(75.9%) |
0.783 |
Female |
21(22.1%) |
13(24.1%) |
|
|
Ethnicity |
|
|
|
Malay |
54(56.8%) |
26(48.1%) |
|
Chinese |
19(20.9%) |
14(25.9%) |
0.859 |
Indian |
14(14.7%) |
9(16.7%) |
|
Others |
8(8.4%) |
5(9.3%) |
|
|
Age, Mean (SD) years |
43.3(18.6) |
46.8(15.5) |
|
<40 |
45(47.4%) |
20(37.0%) |
|
41-60 |
31(32.6%) |
22(40.7%) |
0.238 |
>61 |
19(20.0%) |
12(22.2%) |
|
|
Weight, kg |
70[63-80] |
80[70-86.8] |
|
<50 |
10(10.5%) |
0 |
<0.001* |
51-70 |
25(26.3%) |
12(22.5%) |
|
>71 |
60(63.2%) |
42(77.8%) |
|
|
Length of Stay in ICU (days) |
5[2-8] |
5[3-11.25] |
0.210 |
|
SOFA score, Mean (SD) |
5.8(3.7) |
10.7(4.3) |
|
≤2 |
18(18.9%) |
2(3.7%) |
<0.001* |
>2 |
77(81.1%) |
52(96.3%) |
|
|
Comorbidities |
|
|
|
Diabetes |
17(17.9%) |
17(31.5%) |
0.057 |
Asthma |
7(7.4%) |
3(5.6%) |
0.748 |
Hypertension |
21(22.1%) |
19(35.2%) |
0.083 |
|
Creatinine kinase level on upon diagnosis of rhabdomyolysis |
2179[1246-4742] |
2065[796-7741] |
0.435 |
|
Creatinine kinase level post-treatment |
1578[661-2374] |
2030[764-5548] |
0.048* |
Time taken to reach the highest creatinine kinase (days) |
2[1-2] |
2[1-3] |
0.260 |
|
Mortality |
4(4.2%) |
19(35.2%) |
<0.001* |